Demant A/S

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 14:17:43 01/07/2024 BST			5-day change	1st Jan Change
303.8 ^DKK	+0.80%		-2.68%	+2.91%

06-26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

Demant A/S Provides Earnings Guidance for the Second Half of the Year 2021

November 02, 2021 at 01:00 pm

Demant A/S provided earnings guidance for the second half of the year 2021. For the second half, the company expected LBIT of EUR 50 million to EUR 100 million.

Latest news about Demant A/S

Demant Flags Delay in Completion of Communications Business' Strategic Review	06-26	MT
UK’s Competition Regulator Closes Cochlear-Demant Deal	05-29	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	05-21	MT
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	05-20	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	05-06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	05-06
Hearing Healthcare Company Demant Affirms FY24 Outlook	05-06	MT
Demant A/S Provides Earnings Guidance for the Year 2024	05-06	CI
Denmark's Demant Finalizes Capital Reduction	04-08	MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-04	MT
Demant Seeks Acquisitions	03-12	CI
Transcript : Demant A/S - Analyst/Investor Day	03-12
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	02-28	DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	02-07	CI
Nordic Shares Rose Tuesday; Demant Climbed Highest	02-06	DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	02-06
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	02-06
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024	02-06
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak	02-06	DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	02-06	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-06	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	02-06	MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions	02-05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	02-05	CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024	01-03	CI

Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 04:18 pm

More Strategies

Ratings for Demant A/S

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

301.4 DKK

Average target price

336.7 DKK

Spread / Average Target

+11.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
DEMANT A/S	+2.91%	9.43B
STRAUMANN HOLDING AG	-17.37%	19.75B
SONOVA HOLDING AG	+2.41%	18.42B
COCHLEAR LIMITED	+8.00%	14.51B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-23.29%	1.91B
EMBLA MEDICAL HF.	+7.83%	1.81B
MODERN DENTAL GROUP LIMITED	-.--%	521M
ANGEL ROBOTICS CO., LTD.	-.--%	368M
DELCATH SYSTEMS, INC.	+101.20%	233M
INTEGRUM AB	+25.74%	100M

Medical Prosthetics

Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Demant A/S Provides Earnings Guidance for the Second Half of the Year 2021

Latest news about Demant A/S

Chart Demant A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Demant A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Prosthetics